openPR Logo
Press release

Cancer Tissue Diagnostics Market will Expand at a CAGR of 8.3% During 2016-2026

11-02-2017 08:31 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Future Market Insights

Cancer Tissue Diagnostics Market will Expand at a CAGR of 8.3%

The National Cancer Institute (NCI), which is a part of National Institutes of Health (NIH) in the US estimated 1,685,210 new cases of cancer in the country in 2016. In the same year, NCI also projected 595,690 deaths due to carcinogenic ailments. Cancer research activities have surged rapidly over the past few years, which has led to more product approvals for cancer diagnostic and treatment purposes. A recent study conducted by Future Market Insights (FMI) reveals that the global cancer tissue diagnostics market, which is currently valued at over US$ 4345 Mn, will expand at a healthy CAGR of 8.3% during the forecast period (2016-2026). During these ten years of the forecast, the global demand for cancer tissue diagnostics is expected to grow by leaps and bounds as diagnostic technologies will continue to get more efficient and credible.

Browse Full Report @ https://www.futuremarketinsights.com/reports/cancer-tissue-diagnostics-market

FMI’s report titled “Cancer Tissue Diagnostics Market: Global Industry Analysis and Opportunity Assessment 2016–2026” also cites that North America represents the most lucrative market for cancer tissue diagnostics, followed by Europe and APAC. In 2016, North America accounted for more than 36% share of the global market. The cancer tissue diagnostics market in this region is expected to reach a valuation of US$ 4,017.7 Mn towards the end of 2026. This growth is primarily attributed to factors such as the constantly extending list of cancer biomarkers and the presence of advance healthcare infrastructures in the region. Meanwhile, Asia Pacific excluding Japan (APEJ) is also anticipated to witness a strong growth of its market over the next couple of years. By 2026-end, the region’s market is expected to reach US$ 1,107.7 Mn in terms of revenue.

Report Overview With TOC@ https://www.futuremarketinsights.com/reports/cancer-tissue-diagnostics-market/toc

The National Cancer Institute (NCI), which is a part of National Institutes of Health (NIH) in the US estimated 1,685,210 new cases of cancer in the country in 2016. In the same year, NCI also projected 595,690 deaths due to carcinogenic ailments. Cancer research activities have surged rapidly over the past few years, which has led to more product approvals for cancer diagnostic and treatment purposes. A recent study conducted by Future Market Insights (FMI) reveals that the global cancer tissue diagnostics market, which is currently valued at over US$ 4345 Mn, will expand at a healthy CAGR of 8.3% during the forecast period (2016-2026). During these ten years of the forecast, the global demand for cancer tissue diagnostics is expected to grow by leaps and bounds as diagnostic technologies will continue to get more efficient and credible.

FMI’s report titled “Cancer Tissue Diagnostics Market: Global Industry Analysis and Opportunity Assessment 2016–2026” also cites that North America represents the most lucrative market for cancer tissue diagnostics, followed by Europe and APAC. In 2016, North America accounted for more than 36% share of the global market. The cancer tissue diagnostics market in this region is expected to reach a valuation of US$ 4,017.7 Mn towards the end of 2026. This growth is primarily attributed to factors such as the constantly extending list of cancer biomarkers and the presence of advance healthcare infrastructures in the region. Meanwhile, Asia Pacific excluding Japan (APEJ) is also anticipated to witness a strong growth of its market over the next couple of years. By 2026-end, the region’s market is expected to reach US$ 1,107.7 Mn in terms of revenue.

Buy Full Cancer Tissue Diagnostics Market Report @ https://www.futuremarketinsights.com/checkout/4191

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Tissue Diagnostics Market will Expand at a CAGR of 8.3% During 2016-2026 here

News-ID: 797817 • Views:

More Releases from Future Market Insights

Antibiotics Active Pharmaceutical Ingredient (API) Market Forecast 2026-2036: Market to Reach USD 12,000 Million by 2036 at 2.8% CAGR
Antibiotics Active Pharmaceutical Ingredient (API) Market Forecast 2026-2036: Ma …
NEWARK, DE -The global antibiotics active pharmaceutical ingredient (API) market is projected to reach USD 9,100 million in 2026 and expand to USD 12,000 million by 2036, registering a steady CAGR of 2.8% over the forecast period. This sustained expansion reflects the ongoing need for reliable antibiotic production amid rising bacterial infection prevalence, growing demand for generic antibiotics, and advancements in pharmaceutical manufacturing technologies. The escalating global burden of antimicrobial
Dental Caries and Endodontic Market Forecast 2026-2036: Market to Reach USD 71.6 Billion by 2036 at 6.1% CAGR
Dental Caries and Endodontic Market Forecast 2026-2036: Market to Reach USD 71.6 …
NEWARK, DE -The global Dental Caries and Endodontic Market stands at USD 39.6 billion in 2026 and is projected to expand to USD 71.6 billion by 2036, registering a steady CAGR of 6.1%. This growth reflects the massive global burden of untreated dental caries - the most prevalent health condition worldwide - alongside clinical shifts toward preventive-first models, minimally invasive techniques, and bioactive material adoption. As oral diseases continue to
Drug Discovery Services Market is projected to reach USD 117,163.1 Million by 2036 at a 14.7% CAGR.
Drug Discovery Services Market is projected to reach USD 117,163.1 Million by 20 …
NEWARK, DE -The global Drug Discovery Services Market stands at USD 29,727.4 Million in 2026 and is forecast to expand significantly to USD 117,163.1 Million by 2036, reflecting a robust CAGR of 14.7%. This growth trajectory underscores the pharmaceutical industry's deepening reliance on outsourced models to counter declining internal discovery productivity amid escalating R&D costs. As FDA novel drug approvals increasingly stem from programs leveraging external discovery expertise, both large
Inbound Medical Tourism Market is projected to grow significantly, reaching USD 482.6 Billion by 2036 at a 13.6% CAGR.
Inbound Medical Tourism Market is projected to grow significantly, reaching USD …
NEWARK, DE -The global inbound medical tourism market stands at USD 134.8 Billion in 2026 and is set to expand to USD 482.6 Billion by 2036, reflecting a robust CAGR of 13.6% over the decade. This growth trajectory highlights the sector's evolution into a structured healthcare export industry, driven by government infrastructure commitments, cost advantages in destination countries, and increasing international patient flows for planned treatments. Read Full Report:https://www.futuremarketinsights.com/reports/intrabound-medical-tourism-sector-outlook-and-analysis Market snapshot: global

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For